Home Applications 061455 Application 061455
Type ANDA
Sponsor APOTHECON Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 DICLOXACILLIN SODIUM DICLOXACILLIN SODIUM FOR SUSPENSION;ORAL EQ 62.5MG BASE/5ML No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A061455-001 DICLOXACILLIN SODIUM DICLOXACILLIN SODIUM EQ 62.5MG BASE/5ML FOR SUSPENSION / ORAL Approved before 1982
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-09-29 23:25 UTC 2022-09 A061455-001 DICLOXACILLIN SODIUM EQ 62.5MG BASE/5ML FOR SUSPENSION / ORAL Approved before 1982 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A061455-001 DICLOXACILLIN SODIUM EQ 62.5MG BASE/5ML FOR SUSPENSION / ORAL Approved before 1982 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A061455-001 DICLOXACILLIN SODIUM EQ 62.5MG BASE/5ML FOR SUSPENSION / ORAL Approved before 1982 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 8 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join DICLOXACILLIN SODIUM DICLOXACILLIN SODIUM Redpharm Drug 58e6ee7a-8237-ec66-e063-6394a90a5cae 2026-08-13 Warnings, Adverse reactions Name fallback brand name: DICLOXACILLIN SODIUM generic name: DICLOXACILLIN SODIUM Dicloxacillin Sodium DICLOXACILLIN SODIUM PD-Rx Pharmaceuticals, Inc. c17cd62d-ff5d-47ba-8673-3346c7f2365f 2026-05-21 Warnings, Adverse reactions Name fallback brand name: Dicloxacillin Sodium generic name: DICLOXACILLIN SODIUM Dicloxacillin Sodium DICLOXACILLIN SODIUM PD-Rx Pharmaceuticals, Inc. 9e2bbe03-44cb-45d1-acdb-b61d9016055e 2025-10-20 Warnings, Adverse reactions Name fallback brand name: Dicloxacillin Sodium generic name: DICLOXACILLIN SODIUM Dicloxacillin Sodium DICLOXACILLIN SODIUM PD-Rx Pharmaceuticals, Inc. 24e821aa-85b8-4f5a-aa13-83ff132952ca 2025-10-15 Warnings, Adverse reactions Name fallback brand name: Dicloxacillin Sodium generic name: DICLOXACILLIN SODIUM Dicloxacillin Sodium DICLOXACILLIN SODIUM Bryant Ranch Prepack 3e4842ec-773b-4aeb-b37d-1c4e3cf53424 2024-01-18 Warnings, Adverse reactions Name fallback brand name: Dicloxacillin Sodium generic name: DICLOXACILLIN SODIUM DICLOXACILLIN SODIUM DICLOXACILLIN SODIUM Aurobindo Pharma Limited 9074b5a6-850c-4144-9097-bb21073ee54d 2023-12-27 Warnings, Adverse reactions Name fallback brand name: DICLOXACILLIN SODIUM generic name: DICLOXACILLIN SODIUM Dicloxacillin Sodium DICLOXACILLIN SODIUM Teva Pharmaceuticals USA, Inc. 8478f242-c715-4984-ac1d-dc79dc28665e 2022-06-22 Warnings, Adverse reactions Name fallback brand name: Dicloxacillin Sodium generic name: DICLOXACILLIN SODIUM Dicloxacillin Sodium DICLOXACILLIN SODIUM Asclemed USA, Inc. a4174fda-68f7-4834-be58-dd6b167cf9f0 2020-11-14 Warnings, Adverse reactions Name fallback brand name: Dicloxacillin Sodium generic name: DICLOXACILLIN SODIUM
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.